In a report released today, Liisa Bayko from Evercore ISI maintained a Buy rating on Insmed (INSM – Research Report), with a price target ...

Despite witnessing modest growth in demand over the past three months, Apellis Pharmaceuticals’ complement inhibitor for ...

Many of the coordinated accounts shared similar profile descriptions, reflecting highly partisan narratives tied to religious ...

On Tuesday, Evercore ISI reiterated its ... which includes high-profile films, series, and live events, is expected to contribute positively to the company's performance. Despite higher-than ...

HubSpot Inc. was provided with a boost Wednesday after analysts at Evercore ISI added the stock to their Tactical Outperform ...

Arm Holdings (ARM) was in focus on Thursday after the British semiconductor design company reported fiscal second-quarter ...

Boston Scientific stock pulled back from its run at a record high on Wednesday despite reporting a sweeping third-quarter beat.

Apple (AAPL – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst Toni Sacconaghi from ...

With a positive readout for metabolic dysfunction-associated steatohepatitis (MASH) now in the bag, Novo Nordisk is gearing ...

Arcellx has shared several data cuts on anito-cel, a CAR-T being developed with Gilead’s Kite Pharma to treat relapsed or ...

Ernst & Young LLP, the auditor to troubled server maker Super Micro Computer Inc., has resigned as the company’s registered ...